Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
State Food and Drug Administration General Administration of Customs of the People’s Republic of China
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
(SFDA Decree No. 25)
The Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim), adopted by the State Food and Drug Administration, the General Administration of Customs of the People’s Republic of China and the General Administration of Sport of China, is hereby promulgated in the decree sequence number of the State Food and Drug Administration and shall come into force as of September 1, 2006.
Shao Mingli
Commissioner
State Food and Drug Administration
Mou Xinsheng
Minister
General Administration of Customs of the People’s Republic of China
Liu Peng
Minister
General Administration of Sport of China
July 28, 2006
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
Article 1 The Provisions are formulated with a view to standardizing the administration of import and export of anabolic agents and peptide hormones in accordance with the Drug Administration Law of the People’s Republic of China, Customs Law of People's Republic of China, Anti-doping Regulations and other relevant laws and administrative regulations.
Article 2 The State adopts license control on the import and export of anabolic agents and peptide hormones.
Article 3 The importer shall apply for the importation of anabolic agents and peptide hormones to the State Food and Drug Administration.
Article 4 For the importation of anabolic agents and peptide hormones for medical purpose, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Copy of the Import Drug License (or the Pharmaceutical Product License) (original or duplicate);
(4) Copy of the Drug Supply Certificate, Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importer; to import drug substance and intermediate preparations including preparations to be repackaged in China for their own needs, drug manufacturers shall submit copies of the Drug Manufacturing Certificate, Corporate Business License and Organization Code Certificate;
(5) Where holders of the Import Drug License (or the Pharmaceutical Product License) entrust other companies to export their drugs, they shall provide the authorization letter for export.
All copies mentioned above should be stamped with the official seal of the importer.
Article 5 For the importation of anabolic agents and peptide hormones for teaching and scientific research purposes, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Certificates of legitimate qualifications of users in China, calculation basis for the quantity of the drug in use and letter of guarantee issued by the user for legitimate use and management of the drug;
(4) Approval documents for relevant scientific research projects or approval documents of relevant competent authority;
(5) Where entrusted by users for importation, importers shall provide copies of the authorization agreement, the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importers.
All copies mentioned above should be stamped with the official seal of the importer.
Article 6 Where a enterprise in China entrusted by an overseas enterprise for contract manufacturing needs to import anabolic agents and peptide hormones, it shall provide materials required in Items (1), (3) and (5) of Paragraph 1 of Article 5, in addition, official documents to prove recorded by the local (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government.
All copies mentioned above should be stamped with the official seal of the importer.
Article 7 The State Food and Drug Administration shall decide whether or not to approve the import within 15 working days after receiving the application for import and the relevant materials. Where the application is approved, the State Food and Drug Administration shall issue the Import License for the drug; where the application is not approved, the State Food and Drug Administration shall give reasons in writing.
Article 8 The importer may declare to the customs of the ports where drug importation is permitted upon presenting the Import License for the drug issued by the State Food and Drug Administration. The customs shall clear the drug in the presence of the Import License for the drug.
The Drug Import Note is not required for import of anabolic agents and peptide hormones.
Article 9 To import anabolic agents and peptide hormones including those sold in China for the first time for medical purpose, the importer shall fill in the Import Drug Clearance Form timely after going through the import formalities and submit the following materials in duplicate to the (food and) drug regulatory department where the port of entry is located, upon presenting the original Import Drug License (or the Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug, to apply for the Notice of Import Drug Port Test:
(1) Copies of the Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the Import License for the drug;
(2) Copies of the Drug Manufacturing Certificate or Drug Supply Certificate, and Copy of the Business License for Enterprises as a Legal Person.
(3) Copy of the certificate of origin;
(4) Copy of the purchasing contract;
(5) Copies of packing list, bill of lading and freight invoice;
(6) Copy of the certificate of analysis;
(7) Format of drug insert sheet, package and label (except for drug substance and intermediate preparation);
All copies mentioned above should be stamped with the official seal of the importer.
Article 10 After checking the received Import Drug Clearance Form and relevant materials, the port (food and) drug regulatory department shall return the original Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug to the importer, and send the Notice of Import Drug Port Test, along with a copy of the dossier as prescribed in Article 9 of the Provisions, to the port drug testing institute on the same day.
After receiving the Notice of Import Drug Port Test, the port drug testing institute shall contact the importer within two working days and conduct sampling on the storage site. Upon the completion of the sampling, the mark “sampled” shall be stamped on the back of the first page of the original Import License for the drug, with the seal of sampling institute affixed.
Article 11 Anabolic agents and peptide hormones imported for teaching and research purposes or for the domestic manufacturing contracted by overseas enterprises are exempted from testing.
Article 12 The port (food and) drug regulatory department shall report timely to the State Food and Drug Administration in any of the following circumstances:
(1) The port (food and) drug regulatory department refuses to issue the Notice of Import Drug Port Test in accordance with the provisions in Article 17 of the Provisions for Import Drug (Decree No. 4 of the State Food and Drug Administration and the General Administration of Customs);
(2) The port (food and) drug testing institute refuses the sampling in accordance with the requirements in Article 25 of the Provisions for Import Drug.
The port (food and) drug regulatory department shall take mandatory administrative measures to seal up or seize all the imported drugs within the situations prescribed in the previous paragraph. It shall make the decision of allowing shipping back within seven days from the date of the seal-up or seizure, and inform the importer of applying for the Export License for the drug according to the export procedures for anabolic agents and peptide hormones prescribed in the Provisions and return all the import drugs to the original exporting country.
Where the importer fails to respond or make clear its intention to ship back the drugs within ten days after being informed of the decision, the sealed up or seized drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Article 13 For imported anabolic agents and peptide hormones out of specifications upon testing by the port drug testing institute, the importer shall provide a detailed report about the distribution and use of all the imported drugs to the port (food and) drug regulatory department where the importer is located within two days after receiving the Import Drug Test Report.
After receiving the Import Drug Test Report, the port (food and) drug regulatory departments shall take mandatory administrative measures to timely seal up or seize all the drugs and, within seven days, decide whether or not to place the case on file.
Where the importer fails to apply for a retesting within the specified timeline or the result of the retesting is still out of specifications, the port (food and) drug regulatory department shall make the decision of allowing shipping back and notify the importer to apply for the Export License for the drug according to export procedures for anabolic agents and peptide hormones prescribed in the Provisions to return all the imported drugs to the original exporting country. Where the importer fails to respond or make clear its intention to ship back the drugs within ten days from the date of receiving the decision, the drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Where the result of retesting is in compliance with the specifications, the port (food and) drug regulatory department shall remove the mandatory administrative measures of seal-up and seizure.
The port (food and) drug regulatory department shall handle the case according to the provisions in Paragraph 2, Paragraph 3 and Paragraph 4 of this Article and report the result to the State Food and Drug Administration, and, at the same time, notify the (food and) drug regulatory departments of provinces, autonomous regions and municipalities directly under the Central Government as well as other port (food and) drug regulatory departments.
Article 14 Where domestic drug manufacturers, distributors and medical institutions purchase imported anabolic agents and peptide hormones, the supplier shall provide copies of the Import Drug License (or Pharmaceutical Product License), the Import License for the drug and the Import Drug Test Report, and affix its official seal to the abovementioned copies.
Article 15 The exporter shall apply for exportation of anabolic agents and peptide hormones to the (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government, where it is located, and submit the following materials:
(1) Application Form for Drug Export;
(2) Original import permit (or its copy with notarization) provided by the drug regulatory authority of the importing country or region.
If the importing country or region has no license system in the importation of anabolic agents and peptide hormones, the exporter shall provide the official document (original) of the drug regulatory authority of the importing country or region to prove that the import of the drugs of this type is exempted from the import permit, along with one of the following documents:
a. Original official document (or its copy with notarization) granting import provided by the drug regulatory authority of the importing country or region;
b. Certificates of legitimate qualifications of importers and original supporting document (or its copy with notarization) proving legitimate use of the drug;
(3) Copy of the purchasing contract or order form (except for manufacturers that export their own products);
(4) Copy of the export contract or order form;
(5) Where the export drug is an approved one produced by a domestic manufacturer, the Drug Manufacturing Certificate and Business License for Enterprises as a Legal Person of the manufacturer and a copy of the approval document of the drug shall be provided;
Where the export drug is produced by a domestic enterprise under contract of an overseas enterprise, the exporter shall provide a copy of the official document to prove recorded by the local (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government.
(6) Copies of the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the exporter.
All copies mentioned above should be stamped with the official seal of the exporter.
Article 16 Where the drugs are to be shipped back in accordance with the requirements in Article 12 and Article 13 of the Provisions, the exporter shall provide the following materials to apply for the Export License for the drug:
(1) Documents proving the request for return of goods made by the original exporter of the exporting country;
(2) Import License for the drug.
Article 17 The (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government shall decide whether or not to approve the export within 15 working days after receiving the export application and relevant materials.
Where the application is approved, the regulatory department shall issue the Export License for the drug; where the application is not approved, the regulatory department shall give reasons in writing.
Where the Export License for the drug is applied for in accordance with the requirements in Article 16 of the Provisions, the issuing authority shall mark “return of the original goods” on the Export License for the drug.
Article 18 The exporter may go through the customs formalities upon presenting the Export License for the drug issued by the (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government. The customs shall clear the drug in the presence of the Export License for the drug.
Article 19 The importer and exporter shall provide one more sheet of customs declaration form and apply for sign-back of the sheet when going through the customs formalities. The customs shall stamp the “proof seal” on the sheet in the presence of the Import License for the drug and Export License for the drug. The customs shall charge the cost according to the relevant regulations for issuing certificates.
The importer and exporter shall return the first sheet of the Import License for the drug or Export License for the drug along with the customs declaration form with the seal of the customs, to the issuing regulatory department within one month after completing the import and export.
Where the importer or exporter conducts no relevant importation or exportation after obtaining the Import License for the drug and Export License for the drug, the importer or exporter shall return the original license to the issuing regulatory department within one month after expiration of the license.
Article 20 The validation of the Import License for the drug is one year; the validation of the Export License for the drug is no more than three months (valid within the calendar year).
“One license for one customs clearance” is implemented for the Import License for the drug and Export License for the drug. The license shall be used only once within the validation and its content shall not be altered. Where the import or export is postponed for some reasons, the importer or exporter may request for a new license once with the original one.
Article 21 Where the Import License for the drug or Export License for the drug is lost, the importer or exporter shall report the loss to the original issuing authority in writing immediately. After receiving the loss report, the original issuing authority shall notify the port customs and reissue the license if no harmful consequences are found through confirmation.
Article 22 The Import License for the drug and Export License for the drug are uniformly printed by the State Food and Drug Administration.
Article 23 Where anabolic agents and peptide hormones are imported or exported in the form of processing trade, the customs shall go through and supervise the clearance formalities upon presentation of the Import License for the drug or Export License for the drug. Those not exported for special reasons shall be transferred to and handled by the local (food and) drug regulatory department in accordance with relevant regulations, and the customs shall conduct the verification and cancellation procedures in the presence of relevant documents.
Article 24 Anabolic agents and peptide hormones entering or leaving between bonded zones, export processing zones, other special Customs controlling areas, Customs bonded and controlling areas, with overseas, or between the special Customs controlling areas and the Customs bonded and controlling areas are exempt from application for the Import License for the drug or Export License for the drug, and supervised by the Customs.
Import License for the drug shall be applied for anabolic agents and peptide hormones entering from bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas into other places in China.
Export License for the drug shall be applied for anabolic agents and peptide hormones entering bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas from other places of China.
Article 25 Where an individual carries or mails anabolic agents and peptide hormones, within a reasonable amount, into or out of China for medical needs, the customs shall clear the drugs in the presence of prescriptions of medical institutions in accordance with relevant regulations on prescriptions of the competent health department.
Article 26 Besides prescribed in the Provisions, the importation, port test, supervision and control of anabolic agents and peptide hormones for medical purpose are implemented with reference to requirements related to drug importation in the Provisions for Drug Importation.
Article 27 Anabolic agents and peptide hormones imported for medical purpose mentioned in the Provisions refer to the import anabolic agents and peptide hormones to be used for preparation production or to be marketed in China.
Importer refers to the importer specified on the Import License for the drug obtained in accordance with the Provisions.
Exporter refers to the exporter specified on the Export License for the drug obtained in accordance with the Provisions.
Article 28 These Provisions shall go into effect as of September 1, 2006. The Notice on Import and Export of Anabolic Agents and Peptide Hormones (Guo Shi Yao Jian An [2004] No. 474) issued by the State Food and Drug Administration on September 30, 2004 shall be annulled therefrom.
南京市人民代表大会常务委员会关于修改《南京市防洪堤保护管理条例》的决定
江苏省南京市人大常委会
南京市人民代表大会常务委员会关于修改《南京市防洪堤保护管理条例》的决定
（2004年5月27日南京市第十三届人民代表大会常务委员会第十次会议通过 2004年6月17日江苏省第十届人民代表大会常务委员会第十次会议批准 2004年6月28日南京市人民代表大会常务委员会公告第13号公布 自2004年7月1日起施行）
南京市第十三届人民代表大会常务委员会第十次会议决定对《南京市防洪堤保护管理条例》作如下修改：
一、第十四条第三项修改为：“未经水行政主管部门批准，擅自圈筑围墙、堆放物料、埋设管线；”
二、第十七条修改为：“在市水行政主管部门委托县级水行政主管部门维护管理的防洪堤管理范围和保护范围内，从事第十六条第一款、第二款所列工程设施建设的，应当报市水行政主管部门征求县级水行政主管部门意见后，按照规定的权限进行审批或者审查。”
三、第十九条修改为：“因生产建设需要，确需占用防洪堤的，必须经有关水行政主管部门批准。”
四、第二十一条修改为：“未经水行政主管部门批准，任何单位和个人不得擅自在堤防迎水面前沿从事疏浚、挖河、拦河、堵复河汊、爆破以及在滩地取土、开挖等影响堤防安全的活动。”
五、第二十四条第一款修改为：“涵、闸、泵站的运用必须遵守国家、省、市有关技术规范；汛期必须服从有关防汛指挥机构的调度指挥和监督。”
本决定自2004年7月1日起施行。
《南京市防洪堤保护管理条例》根据本决定作相应修改，重新公布。
附：南京市防洪堤保护管理条例（2004年修正本）
（1999年9月14日南京市第十二届人民代表大会常务委员会第十二次会议制定 1999年10月30日江苏省第九届人民代表大会常务委员会第十二次会议批准 根据2004年5月27日南京市第十三届人民代表大会常务委员会第十次会议通过，2004年6月17日江苏省第十届人民代表大会常务委员会第十次会议批准的《关于修改〈南京市防洪堤保护管理条例〉的决定》修正）
第一条 为了加强对防洪堤的保护和管理，保障防洪安全，根据《中华人民共和国防洪法》等法律、法规的规定，结合本市实际，制定本条例。
第二条 本条例适用于本市行政区域内防洪堤的保护和管理。本市行政区域内由市政设施主管部门管理的防洪堤，按照有关法律、法规的规定执行。
第三条 本条例所称防洪堤，是指具有抵御洪水功能的堤、防洪墙、坝及其配套的涵、闸、泵站等水工程。
第四条 市人民政府水行政主管部门（以下简称市水行政主管部门）负责全市防洪堤的保护和管理工作，县和郊区人民政府水行政主管部门（以下简称县级水行政主管部门）按照规定的职责负责辖区内防洪堤的保护和管理工作。
经市人民政府批准设立的市水利工程管理机构，在市水行政主管部门委托的范围内行使防洪堤保护和管理职能。
市计划、规划、城建、市政公用、交通、国土、公安等部门及城区人民政府应当按照各自的职责，协同市水行政主管部门实施本条例。
第五条 市和县级人民政府应当按照统一管理和分级管理相结合的原则加强领导，明确管理责任，依法安排必需的维护管理资金，确保防洪堤的安全。
第六条 本市防洪堤的分级管理职责划分如下：
（一）长江（南京段）、马汊河、秦淮新河及秦淮河（东山大桥以下河段）的防洪堤由市水行政主管部门管理。
（二）滁河、朱家山河、岳子河、水阳江、石臼湖、固城湖、溧水河、句容河、秦淮河（东山大桥以上河段）和中型水库的防洪堤由市水行政主管部门负责监督管理，其日常维护管理由市水行政主管部门委托所在区域的县级水行政主管部门实施。
（三）其他河道和小型水库的防洪堤由所在区域的县级水行政主管部门管理。
第七条 县、乡边界防洪堤的管理，应当按照上级人民政府的有关规定或者双方的协议执行。管理堤段尚未划定的，市和县级人民政府应当及时划定；在管理堤段划定前，由双方共同管理。
第八条 企事业单位按照受益范围投资建设的防洪堤，经验收合格后纳入本市防洪工程体系，由水行政主管部门负责监督管理，建设单位负责日常维护。
第九条 根据防洪堤保护管理的需要，在防洪堤所在的一定区域划定防洪堤管理范围和保护范围。现有堤防未达到设计标准的，以标准堤设计断面为划定管理范围的依据。
水行政主管部门应当在防洪堤管理范围和保护范围内设立管理标志。
第十条 市水行政主管部门负责管理（含委托管理，下同）的防洪堤管理范围是：
（一）长江（含洲堤）：背水坡堤脚外十五米；背水坡有顺堤河的，以顺堤河为界（含水面，下同）。
（二）马汊河：长江口至大纬路桥段，河中心线两侧各一百三十五米；大纬路桥至葛新桥段，河中心线两侧各一百九十米；葛新桥至小头李段，河中心线两侧各一百三十五米。
（三）秦淮新河：背水坡堤脚外三十米或者堆土区迎水坡坡顶向外三十米。
（四）秦淮河：东山大桥至三汊河段，以南京城市总体规划中的河道管理线（蓝线）为界；东山大桥以上河段（包括句容河和溧水河），背水坡堤脚外三十米。
（五）滁河、朱家山河、岳子河：背水坡堤脚外二十米。
（六）水阳江、固城湖和石臼湖：背水坡堤脚外四十米；有顺堤河的，以顺堤河为界。
（七）中型涵、闸、泵站：上下游河道、堤防各二百米至五百米；左右侧各五十米至二百米。
（八）中型水库：大坝背水坡坝脚外一百米至二百米；大坝两端至山头岗地的顶端；没有山头岗地的，大坝坝端外五十米至一百米。
市水行政主管部门负责管理的防洪堤保护范围是：
（一）江堤（墙）、洲堤、湖堤：背水坡五十米（从管理范围外沿算起，下同）。
（二）河堤：背水坡四十米。
县级水行政主管部门负责管理的防洪堤管理范围和保护范围，由县级人民政府根据实际情况依法划定。
第十一条 新建防洪堤投入使用后，水行政主管部门应当根据所在地的防洪要求和防汛情况，对是否废弃原有的防洪堤作出确认。
未确认废弃的防洪堤，继续按照本条例的规定进行管理；确认废弃的防洪堤，由土地行政主管部门依法进行管理。
第十二条 防洪堤管理范围内土地的确权发证工作由土地行政主管部门依法进行。
防洪堤管理范围内属于国家所有的土地，由水利工程管理机构依法进行使用和管理。其中，已经县级以上人民政府批准，由其他单位或者个人使用的，可继续由原单位或者个人使用。属于集体所有的土地，其所有权和使用权不变。凡以上所有从事生产经营的单位和个人，必须服从水利工程管理机构的安全监督，不得进行损害防洪堤的任何活动。
第十三条 禁止破坏、侵占、损毁防洪堤及其附属设施。
第十四条 在防洪堤管理范围内，不得从事下列活动：
（一）爆破、打井、钻探、建房、建窑、挖窖、葬坟、开采、取土、挖筑鱼塘；
（二）倾倒垃圾、渣土、尾矿或者掩埋危及防洪堤安全的物体；
（三）未经水行政主管部门批准，擅自圈筑围墙、堆放物料、埋设管线；
（四）开展集市贸易、进行考古发掘以及危及防洪堤安全的垦植；
（五）其他危及防洪堤安全的活动。
第十五条 在防洪堤保护范围内，不得从事爆破、打井、钻探、开采、取土、挖筑鱼塘等危及防洪堤安全的活动。
第十六条 建设跨堤、穿堤、临堤的桥梁、码头、道路、渡口、管道、缆线、取水、排水等工程设施的，应当符合防洪标准、岸线规划、航运要求和其他技术要求，不得危及防洪堤安全，其可行性研究报告按照国家规定的基本建设程序报请批准前，其中的工程建设方案应当经有关水行政主管部门根据防洪堤保护和管理要求审查同意。
在防洪堤管理范围内，从事前款工程设施建设的，建设单位应当经有关水行政主管部门对该工程设施建设的位置和界限审查批准后，方可依法办理开工的有关手续；安排施工时，应当按照水行政主管部门审查批准的位置和界限进行。
跨汛期的工程施工，建设单位应当落实汛期安全措施。
第十七条 在市水行政主管部门委托县级水行政主管部门维护管理的防洪堤管理范围和保护范围内，从事第十六条第一款、第二款所列工程设施建设的，应当报市水行政主管部门征求县级水行政主管部门意见后，按照规定的权限进行审批或者审查。
第十八条 在防洪堤管理范围内建设工程设施的，应当接受水行政主管部门的监督检查，并如实提供有关情况和资料。
前款规定的工程设施竣工验收时，组织验收的部门应当通知水行政主管部门参加。
第十九条 因生产建设需要，确需占用防洪堤的，必须经有关水行政主管部门批准。
第二十条 经批准在防洪堤管理范围和保护范围内从事生产建设活动，凡对防洪堤产生不利影响的，生产建设单位和个人必须采取补救措施；造成损坏的，应当负责修复；无力修复的，由水行政主管部门组织修复，所需费用由生产建设单位和个人承担。
第二十一条 未经水行政主管部门批准，任何单位和个人不得擅自在堤防迎水面前沿从事疏浚、挖河、拦河、堵复河汊、爆破以及在滩地取土、开挖等影响堤防安全的活动。
第二十二条 禁止在河道内设置水牮、丁坝等危及堤防安全的建筑物和设施。
第二十三条 在船舶航行可能危及堤防安全的河段，应当限制航速。限制航速的标志，由交通行政主管部门与水行政主管部门商定后设置。通行船舶因超速行驶造成堤防损坏的，应当赔偿损失。
禁止船舶在堤防护坡、挡墙上抛锚。
第二十四条 涵、闸、泵站的运用必须遵守国家、省、市有关技术规范；汛期必须服从有关防汛指挥机构的调度指挥和监督。
严禁非管理人员操作涵、闸和机泵。
第二十五条 水行政主管部门和水利工程管理机构应当定期对防洪堤进行安全检查，发现不安全因素，应当及时采取措施予以排除。
对存在险情的防洪堤，水行政主管部门应当制定加固方案，并及时组织实施加固工程。加固工程所需的资金和物料，有关人民政府应当优先安排。
第二十六条 违反本条例第十六条规定，未经水行政主管部门对其工程建设方案审查同意或者未按照水行政主管部门审查批准的位置、界限，在防洪堤管理范围内从事工程设施建设的，由市和县级水行政主管部门责令其停止违法行为，补办审查或者审批手续；工程设施建设严重影响防洪堤安全的，责令其限期拆除，恢复原状，逾期不拆除的，强行拆除，所需费用由建设单位承担；影响防洪堤安全但尚可采取补救措施的，责令其限期采取补救措施，可以并处一万元以上十万元以下的罚款。
第二十七条 违反本条例规定，有下列行为之一的，由市和县级水行政主管部门责令其停止违法行为，采取补救措施，可以并处罚款：
（一）违反第十三条、第十四条第（一）项、第（二）项、第（三）项、第二十一条、第二十二条规定的，处以五万元以下罚款；
（二）违反第十四条第（四）项、第十五条规定的，处以一万元以下罚款；
（三）违反第十四条第（五）项、第二十四条第二款规定的，处以三千元以下罚款。
第二十八条 水行政主管部门和水利工程管理机构的工作人员滥用职权，玩忽职守，徇私舞弊，致使国家和人民利益遭受损失的，根据情节轻重，由所在单位或者上级主管部门给予行政处分；构成犯罪的，依法追究刑事责任。
第二十九条 本条例自2000年1月1日起施行。
